Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 1/2 2 Phase 4 1 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

OTHER_GOV 1 OTHER 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1889 Carcinoma, Non-Small-Cell Lung 1350 Prostatic Neoplasms 980 Colorectal Neoplasms 851 Multiple Myeloma 741 Leukemia, Myeloid, Acute 725 Neoplasms 691 Lung Neoplasms 680 Neoplasm Metastasis 642 Lymphoma 579 Carcinoma, Hepatocellular 571 Pancreatic Neoplasms 567 Stomach Neoplasms 523 Leukemia 511 Recurrence 493 Leukemia, Lymphocytic, Chronic, B-Cell 459 Precursor Cell Lymphoblastic Leukemia-Lymphoma 452 Melanoma 451 Lymphoma, Non-Hodgkin 443 Ovarian Neoplasms 426 Lymphoma, Large B-Cell, Diffuse 423 Squamous Cell Carcinoma of Head and Neck 416 Myelodysplastic Syndromes 416 Head and Neck Neoplasms 404 Brain Neoplasms 403 Rectal Neoplasms 397 Glioblastoma 375 Carcinoma, Renal Cell 350 Hodgkin Disease 338 Esophageal Neoplasms 337

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Leukoplakia × Clear all

NCT03603223 2025-07-30

Pembrolizumab in Treating Participants With Leukoplakia

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting

Leukoplakia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡